Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment
Hypertrophic cardiomyopathy (HCM) is a very common inherited cardiovascular disease (CAD) and the incidence is about 1/500 of the common population. It is caused by more than 1,400 mutations in 11 or more genes encoding the proteins of the cardiac sarcomere. HCM presents a heterogeneous clinical pro...
Main Authors: | Zeyi Cheng, Tingting Fang, Jinglei Huang, Yingqiang Guo, Mahboob Alam, Hong Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.722340/full |
Similar Items
-
HYPERTROPHIC CARDIOMYOPATHY: GENETIC ALTERATIONS, PATHOGENESIS AND PATHOPHYSIOLOGY
by: N. T. Vatutin, et al.
Published: (2014-05-01) -
Phenotypes of hypertrophic cardiomyopathy. An illustrative review of MRI findings
by: Rafaela Soler, et al.
Published: (2018-10-01) -
An overview of the treatments for hypertrophic cardiomyopathy
by: Wenna Xu, et al.
Published: (2024-06-01) -
Specifics of Left Ventricular Hypertrophy and Characteristic of Phenotypic Variants in Patients with Hypertrophic Cardiomyopathy
by: G. I. Ignatenko, et al.
Published: (2023-08-01) -
Hypertrophic Cardiomyopathy : A Practical Guide to Diagnosis and Management /
by: Adhyapak, Srilakshmi M., editor 635827, et al.
Published: (2021)